Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled Trial
Status:
Completed
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
Accumulating evidence suggests a key role of the N-methyl-D-aspartate (NMDA) receptor in the
pathophysiology of post-traumatic stress disorder (PTSD). Recent studies suggest that the
NMDA receptor antagonist ifenprodil tartrate may be a potential therapeutic drug for PTSD.
The purpose of this study is to confirm whether ifenprodil tartrate is effective in the
treatment of adolescents PTSD patients. If ifenprodil tartrate is effective in these
patients, this study contributes to the development of novel therapeutic drugs for PTSD.